Eton Pharmaceuticals (NASDAQ: ETON) has licensed U.S. rights to ASN-001, a timolol topical gel under development for proliferating superficial infantile ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE